CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH “[***]”. SHARE PURCHASE AGREEMENT...Share Purchase Agreement • March 13th, 2020 • Zealand Pharma a/S • Pharmaceutical preparations • Ontario
COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between Alexion Pharma Holding Unlimited Company and Zealand Pharma A/S. Dated March 20, 2019Collaborative Research and License Agreement • March 13th, 2020 • Zealand Pharma a/S • Pharmaceutical preparations
THIS COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (the “Agreement”), effective as of March 20, 2019 (the “Effective Date”), is entered into by and between Zealand Pharma A/S, a public limited liability company organized under the laws of Denmark having a place of business at Smedland 36, 2600 Glostrup, Copenhagen, Denmark (“ZEALAND”) and Alexion Pharma Holding Unlimited Company, an unlimited liability company incorporated under the laws of Ireland with a principal place of business at 22 Victoria Street, Hamilton HM 12 Bermuda (“ALEXION”, collectively with ZEALAND, the “Parties” and each, a “Party”)
